Valvular & structural heart diseaseCohort study

Contemporary Incidence and Procedural Volume of Transcatheter Aortic Valve Reintervention

JAMA CardiolPublished

  • Retrospective cohort study

Authors' conclusion

In this study, annual volumes of both redo TAVR and TAVR explant continued to increase, particularly in recent years. Redo TAVR is frequently performed over 5 years from the index TAVR.

Study context

Population
Patients with prior transcatheter aortic valve replacement (TAVR) or SAVR undergoing subsequent TAVR or SAVR, US CMS data, January 2012 to June 2024410,720 TAVRs
Participants
2,374 / 1,346 / 5,044 / 4,202
Exposure
Redo TAVR vs TAVR explant
  • Redo TAVRn = 2,374
  • TAVR explantn = 1,346
  • Valve-in-valve (ViV) TAVRn = 5,044
  • Redo SAVRn = 4,202
Outcome
Annual incidence and procedural volume of redo TAVR and TAVR explant

Main finding

As reported in the abstract

TAVR reintervention incidence and volume
GroupValueSince 2020Within 3 months of index TAVR (most common interval)Share of reinterventions beyond 5 years1 to 2 years after index TAVR (most common interval)
Redo TAVR2374 events1518410 of 2374 [17.3%]725 of 819 [88.5%]
TAVR explant1346 events1007259 of 1346 [19.2%]
Annual incidence of TAVR reintervention, 2019 to 2023
0.17% to 0.28%

Observational data: associations, not effects.

Secondary outcomes

events

OutcomeRedo TAVRTAVR explantViV TAVRRedo SAVR
SAVR reintervention volumeNot reported in the abstractNot reported in the abstract50444202
  • SAVR reintervention volume: of 299 780 total SAVRs, 2012–2024

Original publication

Contemporary Incidence and Procedural Volume of Transcatheter Aortic Valve Reintervention. JAMA Cardiol. Published 1 November 2025. doi:10.1001/jamacardio.2025.3224

Summarised from the published abstract; every number is checked against it